Humacyte (HUMA) Interest Expenses (2020 - 2026)

Humacyte (HUMA) has 7 years of Interest Expenses data on file, last reported at $2.3 million in Q1 2026.

• Interest Expenses for Q1 2026 came in at $2.3 million, down 24.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 0.57% YoY), and the FY2025 annual result was $11.2 million, up 21.27% from the prior year.
• Interest Expenses declined to $2.3 million in Q1 2026 per HUMA's latest filing, from $3.1 million in the prior quarter.
• Over five years, Interest Expenses peaked at $3.1 million in Q4 2025 and troughed at $1.4 million in Q1 2022.
• A 5-year average of $2.1 million and a median of $1.8 million in 2024 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2022 and 2026: Interest Expenses soared 168.67% in 2022, then slipped 24.3% in 2026.
• A 5-year view of Interest Expenses shows it stood at $1.6 million in 2022, then climbed by 5.37% to $1.7 million in 2023, then soared by 45.22% to $2.5 million in 2024, then climbed by 23.33% to $3.1 million in 2025, then decreased by 26.58% to $2.3 million in 2026.
• Business Quant data shows HUMA's Interest Expenses at $2.3 million in Q1 2026, $3.1 million in Q4 2025, and $2.6 million in Q3 2025.